The European Partnership for Personalised Medicine (EP PerMed) is a Horizon Europe-funded initiative (launched in Nov 2023) that coordinates research, innovation, and implementation across Europe to accelerate personalised medicine. It brings together national/regional funding bodies, ministries, healthcare providers, industry, researchers, and patients to support the full “value continuum” — from basic research to clinical pilots and health system uptake.  

Key goals include:

  • Translating scientific discoveries into patient-centred applications
  • Integrating big data, digital health, and omics technologies
  • Strengthening health systems’ capacity to adopt personalised approaches
  • Demonstrating the value (clinical, societal, economic) of personalised medicine for sustainable healthcare  

To steer its work, EP PerMed follows a Strategic Research & Innovation Agenda (SRIA) that defines priorities and supports joint calls, pilot projects, capacity building, and policy dialogue.  

Open Calls

Call Announcement - Research, Innovation and Technology Call for Proposals (RITC) 2026
Call Title: Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026). Call Text Link

EP PerMed will fund innovation projects in human health that focus on multimodal data usage for PM approaches aiming to provide more efficient and personalised management of patients with multimorbidity, having at least two chronic diseases that require management and adhere to the definition.

19 funding organizations participate in this call with an available budget of over 14.8 Mio. € (approx.). They have agreed to jointly fund multinational innovative research and technology projects in personalized medicine (PM) to encourage innovative, interdisciplinary public-private partnerships and to support the translational and clinical implementation of research outcomes.

The call will be implemented in two stages, i.e. a pre- and a full proposal phase.

Deadline for pre-proposal submission - 12 January 2026 (14:00, CET)

Deadline for full-proposal submission - 27 April 2026 (14:00, CEST)